Evidence map›Paper›PMID 34782680›Full record

ArticleScientific reports2021

Estimating LOCP cancer mortality rates in small domains in Spain using its relationship with lung cancer.

Garazi Retegui, Jaione Etxeberria, María Dolores Ugarte

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Sex differences in the diagnosis, treatment and prognosis of cancer: the rationale for an individualised approach.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Garazi Retegui *Statistics, Computer Science and Mathematics, Public University of Navarre, 31006, Pamplona, Spain.
Jaione Etxeberria *Statistics, Computer Science and Mathematics, Public University of Navarre, 31006, Pamplona, Spain.
María Dolores Ugarte *Statistics, Computer Science and Mathematics, Public University of Navarre, 31006, Pamplona, Spain. lola@unavarra.es.
Universidad Publica de Navarra · ESNavarre Institute of Health Research · ES

Funding

Spanish Research Agency and Feder MTM2017-82553-RUniversidad Publica de Navarra Proyecto Jóvenes Investigadores PJUPNA2018-11
6 · The paper itself

Abstract

The distribution of lip, oral cavity, and pharynx (LOCP) cancer mortality rates in small domains (defined as the combination of province, age group, and gender) remains unknown in Spain. As many of the LOCP risk factors are preventable, specific prevention programmes could be implemented but this requires a clear specification of the target population. This paper provides an in-depth description of LOCP mortality rates by province, age group and gender, giving a complete overview of the disease. This study also presents a methodological challenge. As the number of LOCP cancer cases in small domains (province, age groups and gender) is scarce, univariate spatial models do not provide reliable results or are even impossible to fit. In view of the close link between LOCP and lung cancer, we consider analyzing them jointly by using shared component models. These models allow information-borrowing among diseases, ultimately providing the analysis of cancer sites with few cases at a very disaggregated level. Results show that males have higher mortality rates than females and these rates increase with age. Regions located in the north of Spain show the highest LOCP cancer mortality rates.

Indexed as

AgedAged, 80 and overAlgorithmsFemaleGeography, MedicalHead and Neck NeoplasmsHumansLip NeoplasmsLung NeoplasmsMaleModels, TheoreticalMouth NeoplasmsPharyngeal NeoplasmsPopulation SurveillanceRisk FactorsSpain

Identifiers

PMID34782680
PMCPMC8593013
OpenAlexW3214272575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.